Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Safa Özçelik, Semih Eren, Kemal Özdemir, Ferdi Peynirci, Yasin Özden, Yavuz Şensöz, Sait Terzi, İlyas Kayacıoğlu
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Aortic stenosis.
10.1016/s0140-6736(09)60211-7 · 2009
2020 ACC/AHA guideline for the management of patients with valvular heart disease.
2021
2021 ESC/EACTS guidelines for the management of valvular heart disease.
10.1093/eurheartj/ehab395 · 2022
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
10.1056/nejmoa1008232 · 2010
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
10.1056/nejmoa1103510 · 2011
Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.
10.1056/nejmoa1700456 · 2017
Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.
10.1056/nejmoa1814052 · 2019
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
10.1056/nejmoa1816885 · 2019
Aortic valve reconstruction using autologous pericardium for patients aged less than 60 years.
10.1016/j.jtcvs.2014.05.041 · 2014
Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium.
10.1016/j.jtcvs.2018.01.087 · 2018
Hemodynamics and structural mechanics of the aortic valve after Ozaki procedure: a systematic review.
2025
Five-year outcomes of transcatheter or surgical aortic-valve replacement.
10.1056/nejmoa1910555 · 2020
Conduction disturbances after transcatheter aortic valve replacement.
10.1161/circulationaha.117.028352 · 2017
Predictors of permanent pacemaker implantation following TAVR: a meta-analysis.
10.1016/j.jacc.2014.04.033 · 2014
Vancouver transcatheter aortic valve replacement clinical pathway.
10.1161/circoutcomes.115.002541 · 2016
The Vancouver 3M clinical pathway facilitates safe next-day discharge home after TAVR.
10.1016/j.jcin.2018.12.020 · 2019
Prosthesis–patient mismatch: definition, clinical impact, and prevention.
10.1016/s0735-1097(00)00859-7 · 2000
Mechanical versus bioprosthetic aortic valve replacement.
10.1093/eurheartj/ehx141 · 2017
Five-year clinical and echocardiographic outcomes from the NOTION randomized trial.
10.1161/circulationaha.118.036606 · 2019
Five-year clinical and echocardiographic outcomes from the NOTION randomized trial.
10.1161/circulationaha.118.036606 · doi-reference
The Vancouver 3M clinical pathway facilitates safe next-day discharge home after TAVR.
10.1016/j.jcin.2018.12.020 · doi-reference
Vancouver transcatheter aortic valve replacement clinical pathway.
10.1161/circoutcomes.115.002541 · doi-reference
Prosthesis–patient mismatch: definition, clinical impact, and prevention.
10.1016/s0735-1097(00)00859-7 · doi-reference
Mechanical versus bioprosthetic aortic valve replacement.
10.1093/eurheartj/ehx141 · doi-reference
Predictors of permanent pacemaker implantation following TAVR: a meta-analysis.
10.1016/j.jacc.2014.04.033 · doi-reference
Conduction disturbances after transcatheter aortic valve replacement.
10.1161/circulationaha.117.028352 · doi-reference
Five-year outcomes of transcatheter or surgical aortic-valve replacement.
10.1056/nejmoa1910555 · doi-reference
Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium.
10.1016/j.jtcvs.2018.01.087 · doi-reference
Aortic valve reconstruction using autologous pericardium for patients aged less than 60 years.
10.1016/j.jtcvs.2014.05.041 · doi-reference
Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
10.1056/nejmoa1816885 · doi-reference
Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.
10.1056/nejmoa1814052 · doi-reference
Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.
10.1056/nejmoa1700456 · doi-reference
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
10.1056/nejmoa1103510 · doi-reference
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
10.1056/nejmoa1008232 · doi-reference
2021 ESC/EACTS guidelines for the management of valvular heart disease.
10.1093/eurheartj/ehab395 · doi-reference
Aortic stenosis.
10.1016/s0140-6736(09)60211-7 · doi-reference